Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (191-200 of 315) with videos related to

Pageof 32
Sort By:
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II TrialJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningNiraj C Patel, Javier Chinen, Howard M Rosenblatt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host diseaseCaron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Nature Communications|January 3, 2024
Integrative genotyping of cancer and immune phenotypes by long-read sequencingLivius Penter, Mehdi Borji, Adi Nagler, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Blood|June 4, 2014
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemiaMohini Rajasagi, Sachet A Shukla, Edward F Fritsch, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Pageof 32

Showing results (191-200 of 315) with videos related to

Sort By:
Pageof 32
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II TrialJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningNiraj C Patel, Javier Chinen, Howard M Rosenblatt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host diseaseCaron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Nature Communications|January 3, 2024
Integrative genotyping of cancer and immune phenotypes by long-read sequencingLivius Penter, Mehdi Borji, Adi Nagler, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Blood|June 4, 2014
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemiaMohini Rajasagi, Sachet A Shukla, Edward F Fritsch, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Pageof 32